Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.4B; returns 1 day -0.4%, 1 week +3.5%, 1 year +543.4%.

Iovance Biotherapeutics Inc. is a commercial-stage biotechnology company primarily focused on developing and commercializing tumor-infiltrating lymphocyte (TIL) cell therapies for solid tumors.

Groups IOVA belongs to

• Biotechnology
• Oncology
• Commercial Stage Biotech
• Autologous Cell Therapy
• Healthcare
• Cancer Therapeutics
• Biopharmaceutical
• Immunotherapy
• Life Sciences
• Pharmaceuticals
• Commercial Stage
• Biologics
• Unmet Medical Needs
• Precision Medicine

IOVA financial model: income statement, cash flow and balance sheet